Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment

Analysis of the Association of Products for the Treatment of Cervical Dentin Hypersensitivity

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02931734

Acronym

CDH

Enrollment

140

Registered

2016-10-13

Start date

2014-10-31

Completion date

2015-07-31

Last updated

2016-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentine Hypersensitivity, Dentin Hypersensitivity, Dentin Sensitivity, Hypersensitivity Dentin

Brief summary

The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity by the agents Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Detailed description

Cervical dentin hypersensitivity is a painful condition and is a clinical challenge due to different treatment strategies available. The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity. A hundred forty teeth of healthy patients of both sexes were selected. Visual Analog Scale was used pain (VAS) to measure the intensity of the patient's pain. The teeth will be randomly divided into 7 different groups according to the desensitization treatment under study: Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Interventions

DRUGResin modified glass ionomer

Prophylaxis, washing and removing water excess , apply the Clinpro forming a uniform layer of 0.5mm, lightcure for 20 seconds

DRUGPotassium Nitrate 2%

Prophylaxis, apply uniformly on the teeth, wait 10 minutes, remove the gel from the teeth with cotton and abundant water.

PROCEDURELow level laser therapy

Prophylaxis, applying infrared laser at low power in points: mesial, buccal, distal and in the apical point in the foyer of fornix with power of 110MW for 11 seconds at each point.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* presence of dentin exposure lesions with clinical diagnosis of moderate or severe tooth sensitivity * good oral hygiene.

Exclusion criteria

* cavities, * presence of periodontal disease and or parafunctional habits, * cracks or enamel fractures, * extensive or unsatisfactory restorations, * recent restorations involving the labial surface, * dentures, * orthodontics.

Design outcomes

Primary

Measure	Time frame	Description
Level of cervical dentin hypersensitivity, measured by visual analog scale	24 weeks	Evaluate the reduction in Cervical Dentin Hypersensitivity with a 24 weeks follow up.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026